Search results for "GLUCOSE"

showing 10 items of 1206 documents

NEW INTERPRETATION OF ORAL GLUCOSE TOLERANCE

1964

medicine.medical_specialtyGlucose tolerance testmedicine.diagnostic_testDuodenumbusiness.industryResearchGeneral MedicineGlucose Tolerance TestGastroenterologyIntestinal absorptionInjectionsJejunumDogsGlucoseJejunummedicine.anatomical_structureIntestinal AbsorptionInternal medicineInjections IntravenousmedicineDuodenumAnimalsOral glucose tolerancebusinessThe Lancet
researchProduct

Effects of Fasting and Glucose Load on Free Cortisol Responses to Stress and Nicotine1

1997

The availability of energy appears to exert important regulatory functions in pituitary-adrenal stress responses. In two studies, the effects of short-term fasting and subsequent glucose administration on the free cortisol response to psychological stress and nicotine consumption were investigated. Study 1: After fasting for 8-11 h, healthy young men ingested either 100 g glucose (n = 13) or water (n = 12). One hour later they were exposed to a psychosocial stress task (Trier Social Stress Test). A third group also ingested 100 g glucose, but they were not exposed to any additional treatment (n = 10). Capillary blood glucose levels were in the lower euglycemic range before and significantly…

medicine.medical_specialtyGlucose tolerance testmedicine.diagnostic_testbusiness.industryEndocrinology Diabetes and Metabolismmedicine.medical_treatmentBiochemistry (medical)Clinical BiochemistryStimulationBiochemistryNicotineSteroid hormoneEndocrinologyEndocrinologyInternal medicinemedicineTrier social stress testAnimal studiesbusinessGlucocorticoidmedicine.drugHydrocortisoneThe Journal of Clinical Endocrinology & Metabolism
researchProduct

Diabetes Secondary to Acromegaly: Physiopathology, Clinical Features and Effects of Treatment.

2018

Acromegaly is a rare disease due to chronic GH excess and to the consequent increase in IGF-1 levels. Both GH and IGF-1 play a role in intermediate metabolism affecting glucose homeostasis. Indeed, chronic GH excess impairs insulin sensitivity, increases gluconeogenesis, reduces the glucose uptake in adipose tissue and muscle and alters pancreatic β cells function. As a consequence, glucose metabolism alterations are a very frequent complication in acromegaly patients, further contributing to the increased cardiovascular risk and mortality. Treatment modalities of acromegaly differently impact on glucose tolerance. Successful surgical treatment of acromegaly ameliorates glucose metabolism a…

medicine.medical_specialtyGlucose uptakeMini Reviewglucose metabolismEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismCarbohydrate metabolismpituitary tumorlcsh:Diseases of the endocrine glands. Clinical endocrinologySettore MED/13 - EndocrinologiaImpaired glucose tolerance03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEndocrinologyInternal medicineDiabetes mellitusAcromegalymedicineGlucose homeostasislcsh:RC648-665diabetesbusiness.industrymedicine.diseasePasireotideGHEndocrinologyimpaired glucose toleranceAcromegaly Diabetes GH Glucose metabolism IGF-1 Impaired glucose tolerance Pituitary tumor Endocrinology Diabetes and Metabolismchemistry030220 oncology & carcinogenesisPegvisomantAcromegalyIGF-1businessmedicine.drug
researchProduct

Hypertension, diabetes mellitus, and insulin resistance: the role of intracellular magnesium.

1997

Magnesium is one of the most abundant ions present in living cells and its plasma concentration is remarkably constant in healthy subjects. Plasma and intracellular magnesium concentrations are tightly regulated by several factors. Among them, insulin seems to be one of the most important. In fact, in vitro and in vivo studies have demonstrated that insulin may modulate the shift of magnesium from extracellular to intracellular space. Intracellular magnesium concentration has also been shown to be effective on modulating insulin action (mainly oxidative glucose metabolism), offset calcium-related excitation-contraction coupling, and decrease smooth cell responsiveness to depolarizing stimul…

medicine.medical_specialtyGlucose uptakemedicine.medical_treatmentchemistry.chemical_elementCarbohydrate metabolismDiabetes Mellitus ExperimentalInsulin resistanceInternal medicineDiabetes mellitusInternal MedicinemedicineDiabetes MellitusAnimalsHumansInsulinMagnesiumbiologyMagnesiumbusiness.industryInsulinmedicine.diseaseInsulin receptorEndocrinologychemistryHypertensionbiology.proteinInsulin ResistancebusinessIntracellularAmerican journal of hypertension
researchProduct

The Effects of Self-Control on Glucose Utilization in a Hyperinsulinemic Euglycemic Glucose Clamp

2019

Abstract. Background. The glucose hypothesis of self-control posits that acts of self-control may draw upon glucose as a source of energy, leading to a decrease in blood glucose levels after exerting self-control, mirroring the temporary depletion of self-control, but supporting evidence is mixed and inconclusive. This might partly be due to using methods that are not suitable to reliably quantify glucose utilization. Aims. We aimed at examining whether self-control exertion leads to an increase in glucose utilization. Method. In a sample of N = 30 healthy participants (50% women, age 26.5 ± 3.5 years) we combined a hyperinsulinemic euglycemic glucose clamp (a well-established and validate…

medicine.medical_specialtyGlucose utilizationEgo depletionChemistrymedia_common.quotation_subject05 social sciencesBlood sugar050109 social psychologySelf-control050105 experimental psychologyPsychiatry and Mental healthClinical PsychologyEndocrinologyClampInternal medicinemedicine0501 psychology and cognitive sciencesmedia_commonEuropean Journal of Health Psychology
researchProduct

Seven-day subcutaneous continuous glucose monitoring demonstrates that treatment with acarbose attenuates late dumping syndrome in a woman with gastr…

2013

medicine.medical_specialtyGlycoside Hydrolase InhibitorsContinuous glucose monitoringbusiness.industryEndocrinology Diabetes and Metabolismmedicine.medical_treatmentCancerGeneral Medicinedumping syndrome acarbose hypoglycemiaCarbohydrate metabolismmedicine.diseaseGastroenterologyLate dumping syndromeEndocrinologyEndocrinologyDiabetes mellitusInternal medicineInternal MedicinemedicineGastrectomybusinessAcarbosemedicine.drug
researchProduct

Lindane-induced changes in carbohydrate metabolism in Anguilla anguilla

1992

Abstract 1. Anguilla anguilla (L.) was exposed to a sublethal concentration of 0.167 ppm (0.25 of the 96-hr lc 50 ) of lindane for 6, 12, 24, 48, 72 and 96 hr. 2. Changes in glycogen, glucose, pyruvate and lactate contents of liver and muscle after lindane exposure, were studied. 3. Muscle and liver glycogen levels decreased significantly during the exposure time. Muscle glucose values increased but on the other hand we found a decrease in those of liver. 4. Muscle and liver pyruvate content increased as did lactate levels in both tissues. 5. The observed effects of lindane on carbohydrate metabolism in fish are discussed in relation to acute stress syndrome.

medicine.medical_specialtyImmunologyBiologyCarbohydrate metabolismchemistry.chemical_compoundInternal medicinePyruvic AcidmedicineAnimalsLactic AcidAcute stressPyruvatesPharmacologyGlycogenMusclesMetabolismCarbohydrateAnguillaGlucoseEndocrinologyLiverchemistryLactatesCarbohydrate MetabolismFish <Actinopterygii>LindaneGlycogenHexachlorocyclohexaneComparative Biochemistry and Physiology Part C: Comparative Pharmacology
researchProduct

NAD- and NADP-linked dehydrogenases in the sciatic nerve of rats injected with di-isopropylfluorophosphate.

1966

medicine.medical_specialtyIsoflurophateL-Lactate DehydrogenaseChemistryGeneral NeuroscienceAnatomyGlucosephosphate DehydrogenaseIn Vitro TechniquesNADSciatic NerveRatsEndocrinologyMalate DehydrogenaseInternal medicinemedicineAnimalsNeurology (clinical)Sciatic nerveNAD+ kinaseMolecular BiologyNADPDevelopmental BiologyBrain research
researchProduct

Adipokines and Lipoproteins: Modulation by Antihyperglycemic and Hypolipidemic Agents

2014

Abstract Adipose tissue is an endocrine organ that secretes a number of hormones and metabolically active substances that impact energy metabolism and insulin sensitivity. These inflammatory markers are collectively referred to as adipocytokines, or adipokines. Adipose tissue's functional capacity and metabolic activity vary among individuals, thus partly explaining the incomplete overlap between obesity and the metabolic syndrome. The functional failure of adipose tissues results in changed energy delivery and impaired glucose consumption, triggering self-regulatory mechanisms to maintain homeostasis. Antihyperglycemic, hypolipidemic, antiobesity, and angiotensin II receptor blocker drugs …

medicine.medical_specialtyLipoproteinsEndocrinology Diabetes and Metabolismmedicine.medical_treatmentAdipokineAdipose tissueIncretinsNiacinAnti-Obesity AgentsInsulin resistanceAdipokinesInternal medicineInternal MedicineAnimalsHumansHypoglycemic AgentsInsulinMedicineHypolipidemic AgentsMetabolic Syndromebusiness.industryInsulinFibric AcidsEzetimibemedicine.diseaseLipidsMetforminGlucoseEndocrinologyAdipose TissueHypolipidemic AgentsAzetidinesThiazolidinedionesAnti-Obesity AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsInsulin ResistanceMetabolic syndromebusinessHormoneMetabolic Syndrome and Related Disorders
researchProduct

Incretin-Based Therapies, Glucometabolic Health and Endovascular Inflammation

2013

Incretin peptides are a group of gastrointestinal hormones that play a prominent role in the regulation of glucose metabolism. Incretin-based therapies (IBTs) have recently emerged as an important treatment option for patients with type 2 diabetes mellitus (T2DM). These pharmaceutical agents may be specially well suited for patients who are overweight or obese with primarily post-meal glucose peaks, and in whom traditional first-line oral agents have failed to maintain adequate glycemic control. There are 2 classes of IBTs: the dipeptidyl peptidase-4 (DPP-4) inhibitors and the glucagon-like peptide 1 (GLP-1) receptor agonists. The ultimate effect of both types of agents is to augment GLP-1 …

medicine.medical_specialtyLipoproteinsIncretin type 2 diabetes mellitus metabolic syndrome lipoproteinsIncretinBiologyIncretinsGlucagon-Like Peptide-1 ReceptorWeight lossDiabetes mellitusInternal medicineDrug DiscoverymedicineAnimalsHumansGlucose homeostasisAdiponectin secretionLipoproteinInflammationPharmacologyDipeptidyl-Peptidase IV InhibitorsDrug Discovery3003 Pharmaceutical ScienceMedicine (all)digestive oral and skin physiologyGlucagon secretionType 2 Diabetes MellitusIncretinAtherosclerosismedicine.diseaseMetabolic syndromeType 2 diabetes mellituGlucoseEndocrinologyDiabetes Mellitus Type 2Metabolic syndromemedicine.symptomCurrent Pharmaceutical Design
researchProduct